Page last updated: 2024-08-23

pyoluteorin and ER-Negative PR-Negative HER2-Negative Breast Cancer

pyoluteorin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ding, T; Shen, YH; Yang, LJ; Zhang, WD	1

Other Studies

1 other study(ies) available for pyoluteorin and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231. The Journal of pharmacy and pharmacology, 2020, Volume: 72, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Discovery; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Membrane Potential, Mitochondrial; Phenols; Pyrroles; Triple Negative Breast Neoplasms	2020

Article

Year

Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.

The Journal of pharmacy and pharmacology, 2020, Volume: 72, Issue:7

Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Discovery; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Membrane Potential, Mitochondrial; Phenols; Pyrroles; Triple Negative Breast Neoplasms

2020